Novel TSHB variant (c.217A>C) causing severe central hypothyroidism and pituitary hyperplasia

Biallelic pathological variants in the thyroid stimulating hormone (TSH) subunit β gene (TSHB) result in isolated TSH deficiency and secondary hypothyroidism, a rare form of central congenital hypothyroidism (CCH), with an estimated incidence of 1 in 65 000 births. It is characterised by low levels...

Full description

Bibliographic Details
Main Authors: Adam I Kaplan, Catherine Luxford, Roderick J Clifton-Bligh
Format: Article
Language:English
Published: Bioscientifica 2022-08-01
Series:Endocrinology, Diabetes & Metabolism Case Reports
Online Access:https://edm.bioscientifica.com/view/journals/edm/2022/1/EDM22-0230.xml
_version_ 1798041626907508736
author Adam I Kaplan
Catherine Luxford
Roderick J Clifton-Bligh
author_facet Adam I Kaplan
Catherine Luxford
Roderick J Clifton-Bligh
author_sort Adam I Kaplan
collection DOAJ
description Biallelic pathological variants in the thyroid stimulating hormone (TSH) subunit β gene (TSHB) result in isolated TSH deficiency and secondary hypothyroidism, a rare form of central congenital hypothyroidism (CCH), with an estimated incidence of 1 in 65 000 births. It is characterised by low levels of free thyroxine and inappropriately low serum TSH and may therefore be missed on routine neonatal screening for hypothyroidism, which relies on elevated TSH. We describe a patient with CCH who developed recurrence of pituitary hyperplasia and symptomatic hypothyroidism due to poor compliance with thyroxine replacement. She was diagnosed with CCH as a neonate and had previously required trans-sphenoidal hypophysectomy surgery for pituitary hyperplasia associated with threatened chiasmal compression at 17 years of age due to variable adherence to thyroxine replacement. Genetic testing of TSHB identified compound heterozygosity with novel variant c.217A>C, p.(Thr73Pro), and a previously reported variant c.373delT, p.(Cys125Valfs*10). Continued variable adherence to treatment as an adult resulted in recurrence of significant pituitary hyperplasia, which subsequently resolved with improved compliance without the need for additional medications or repeat surgery. This case describes a novel TSHB variant associated with CCH and demonstrates the importance of consistent compliance with thyroxine replacement to treat hypothyroidism and prevent pituitary hyperplasia in central hypothyroidism.
first_indexed 2024-04-11T22:24:17Z
format Article
id doaj.art-dacbc6b897e242f2b01a969f33f1021a
institution Directory Open Access Journal
issn 2052-0573
language English
last_indexed 2024-04-11T22:24:17Z
publishDate 2022-08-01
publisher Bioscientifica
record_format Article
series Endocrinology, Diabetes & Metabolism Case Reports
spelling doaj.art-dacbc6b897e242f2b01a969f33f1021a2022-12-22T03:59:53ZengBioscientificaEndocrinology, Diabetes & Metabolism Case Reports2052-05732022-08-01111710.1530/EDM-22-0230Novel TSHB variant (c.217A>C) causing severe central hypothyroidism and pituitary hyperplasiaAdam I Kaplan0Catherine Luxford1Roderick J Clifton-Bligh2Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Department of Endocrinology, Royal North Shore Hospital, Sydney, Australia Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Cancer Genetics Laboratory, Kolling Institute, Royal North Shore Hospital, Sydney, Australia Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Department of Endocrinology, Royal North Shore Hospital, Sydney, Australia; Cancer Genetics Laboratory, Kolling Institute, Royal North Shore Hospital, Sydney, Australia Biallelic pathological variants in the thyroid stimulating hormone (TSH) subunit β gene (TSHB) result in isolated TSH deficiency and secondary hypothyroidism, a rare form of central congenital hypothyroidism (CCH), with an estimated incidence of 1 in 65 000 births. It is characterised by low levels of free thyroxine and inappropriately low serum TSH and may therefore be missed on routine neonatal screening for hypothyroidism, which relies on elevated TSH. We describe a patient with CCH who developed recurrence of pituitary hyperplasia and symptomatic hypothyroidism due to poor compliance with thyroxine replacement. She was diagnosed with CCH as a neonate and had previously required trans-sphenoidal hypophysectomy surgery for pituitary hyperplasia associated with threatened chiasmal compression at 17 years of age due to variable adherence to thyroxine replacement. Genetic testing of TSHB identified compound heterozygosity with novel variant c.217A>C, p.(Thr73Pro), and a previously reported variant c.373delT, p.(Cys125Valfs*10). Continued variable adherence to treatment as an adult resulted in recurrence of significant pituitary hyperplasia, which subsequently resolved with improved compliance without the need for additional medications or repeat surgery. This case describes a novel TSHB variant associated with CCH and demonstrates the importance of consistent compliance with thyroxine replacement to treat hypothyroidism and prevent pituitary hyperplasia in central hypothyroidism.https://edm.bioscientifica.com/view/journals/edm/2022/1/EDM22-0230.xml
spellingShingle Adam I Kaplan
Catherine Luxford
Roderick J Clifton-Bligh
Novel TSHB variant (c.217A>C) causing severe central hypothyroidism and pituitary hyperplasia
Endocrinology, Diabetes & Metabolism Case Reports
title Novel TSHB variant (c.217A>C) causing severe central hypothyroidism and pituitary hyperplasia
title_full Novel TSHB variant (c.217A>C) causing severe central hypothyroidism and pituitary hyperplasia
title_fullStr Novel TSHB variant (c.217A>C) causing severe central hypothyroidism and pituitary hyperplasia
title_full_unstemmed Novel TSHB variant (c.217A>C) causing severe central hypothyroidism and pituitary hyperplasia
title_short Novel TSHB variant (c.217A>C) causing severe central hypothyroidism and pituitary hyperplasia
title_sort novel tshb variant c 217a c causing severe central hypothyroidism and pituitary hyperplasia
url https://edm.bioscientifica.com/view/journals/edm/2022/1/EDM22-0230.xml
work_keys_str_mv AT adamikaplan noveltshbvariantc217accausingseverecentralhypothyroidismandpituitaryhyperplasia
AT catherineluxford noveltshbvariantc217accausingseverecentralhypothyroidismandpituitaryhyperplasia
AT roderickjcliftonbligh noveltshbvariantc217accausingseverecentralhypothyroidismandpituitaryhyperplasia